Back to search

National and Kapodistrian University of Athens

Λειτουργική ικανότητα υπερπληθυσμών λεμφoκυττάρων ασκιτικού υγρού ασθενών με καρκίνο των ωοθηκών: συσχέτιση με κλινικοπαθολογοανατομικά δεδομένα

Abstract

dc:description

Human prothymosin alpha (ProTα) is an evolutionary conserved, highly acidic polypeptide of 109 amino acids, with potent immunoenhancing properties in vitro and in vivo. These effects, are attributed to its carboxy (C)-terminal decapeptide, ProTα(100-109).Herein, we investigated the in vitro effect of ProTα and its immunologically active fragment, in synergy with interleukin-2 (IL–2), on the immune responses of lymphocytes isolated from the ascitic fluid of ovarian cancer patients. Hence, lymphocytes isolated from the ascites of 33 untreated ovarian cancer patients (FIGO stage IIIC) were cultured ex vivo in mixed lymphocyte-tumor cultures (MLTC) with ProTα or ProTα(100-109), in synergy with low concentration of IL–2. Cells incubated with low dose IL–2 were used as comparator. Lymphocytes were restimulated weekly, with ascites-derived monocytes and autologous cancer cells for 7-21 days. On days 7, 14 and 21, lymphocytes were tested for their cytotoxicity and their phenotype. Briefly, for the cytotoxicity assays, we used autologous tumor cells as for CD8+T cell targets (MHC-restricted cytotoxicity) and K562 cells as for NK/NKT cell targets (non MHC-restricted cytotoxicity). Targets (T) were labeled with 51Cr and after 18 hours co-incubation with the effectors (E) at an E:T ratio of 40:1, released radioactivity was determined with a γ-counter. For immunophenotype analysis, FITC, PE or PE/Cy labeled anti-CD45, anti-CD56, anti-CD3, anti-CD4 and anti-CD8 mAbs were used. Flow cytometry was conducted on a FACScan (Becton-Dickinson) flow cytometer and data were analyzed using CellQuest. All data were statistically evaluated by paired t-test. p values were two-sided and 5% was chosen to denote significance. SPSS v.13.0 software was used for the analysis. ProTα and its immunoreactive peptide proTα(100-109), enhanced the cytotoxic activity of tumor-associated lymphocytes (TALs), against autologous tumor cells in vitro, ( ~20% vs 12.5%, p = 0.001 for day 7/ ~18% vs 11%, p = 0.003 for day 14) having a less important effect (p = 0.073) on the lysis of NK sensitive targets. The effect of ProTα and ProTα(100-109), was higher during the first 14 days of stimulation. The cytotoxic potential of ProTα(100-109) was found to be at least equal with that of the whole peptide of ProTα. It should be noted that, this is the first report showing the immunoenhancing activity of ProTα/ProTα(100-109) on lymphocytes isolated from ascitic fluids of patients with ovarian cancer. No correlation was mentioned between the aforementioned results and clinical parameters such as patient’s age, tumor histology, grade or response to therapy.Our data demonstrate that, ProTα and ProTα(100-109), can induce the cytotoxic potential of lymphocytes. In the presence of tumor antigens, they enhance the depressed cytotoxicity of TALs against autologous tumor cells in vitro, overturning the effects of a heavily immunosuppressive environment, such as the ascetic fluid of ovarian cancer patients.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2013

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Pistamaltzian, Nikolaos
  • Πισταμαλτζιάν, Νικόλαος

Subjects

dc:subject × 26

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/35670

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Pistamaltzian, Nikolaos; Πισταμαλτζιάν, Νικόλαος. Λειτουργική ικανότητα υπερπληθυσμών λεμφoκυττάρων ασκιτικού υγρού ασθενών με καρκίνο των ωοθηκών: συσχέτιση με κλινικοπαθολογοανατομικά δεδομένα. National and Kapodistrian University of Athens, 2013. http://hdl.handle.net/10442/hedi/35670